Click here to subscribe FREE to Ray Hanania's Columns
Calder Cup Champions Chicago Wolves sign two veterans forwards
The Calder Cup champs add LaBate and Melnick from Central Division rivals
The Calder Cup champion Chicago Wolves announced Monday they have signed forwards Joseph LaBate and Josh Melnick to Standard Player Contracts (SPC).
LaBate, 29, has produced 52 goals, 59 assists and 592 penalty minutes in eight AHL seasons with Utica, Belleville and Milwaukee. The Eagan, Minnesota, native also earned 13 NHL games with the Vancouver Canucks during the 2016-17 season.
Last year, the University of Wisconsin graduate contributed 5 goals, 7 assists and a team-high 121 penalty minutes in 56 games for the Admirals.
Melnick, 27, notched 10 goals and 12 assists in 56 appearances last year for the Texas Stars. The Annandale, New Jersey, native and Miami (Ohio) alum posted 24 goals and 29 assists in 160 games spread across four seasons for the Stars.
Head coach Ryan Warsofsky’s Wolves are preparing to defend their American Hockey League championship and plan to announce their home opener and full schedule soon.
To find the latest information on Calder Cup championship merchandise, official home dates and the team’s roster, visit ChicagoWolves.com or contact a team representative at [email protected].
Click here to subscribe FREE to Ray Hanania's Columns
His award winning columns can be found at www.HANANIA.COM Subscribe FREE today
Hanania also writes about Middle East issues for the Arab News, and The Arab Daily News criticizing government policies in the Israeli-Palestinian conflict.
Hanania was named "Best Ethnic American Columnist" by the New America Media in November 2007, and is the 2009 recipient of the SPJ National Sigma Delta Chi Award for column writing.
Email Ray Hanania at [email protected].
Follow RayHanania at Twitter
- Moderate Jewish Lobby J Street denounces Trump war on Iran - February 28, 2026
- Sean Casten Statement on US Military Action in Iran - February 28, 2026
- Phil Andrew: Attack on Iran Without Congressional Approval Risks American Lives - February 28, 2026
